shRNA gene silencing Human Neuroblastoma cells (SH-SY5Y)

- Found 8814 results

Site-directed mutagenesis (SDM) can be challenging, particularly during detection/confirmation of (SDM) in colonies by sequencing or PCR techniques. This common issue in SDM is heavily relying on designing of mutagenic primer pairs. The best solution is to design the mutagenic primers that have extended 3'-ends/3'-overhang. This would provide the annealing region between the mutagenic primer pair is essentially shorter. and hence ensure a lower annealing temperature for the primer pair along with a higher chance of annealing to the template.

DNA Site Directed Mutagenesis (SDM) Human Deletion SKOV3 APRIN

Get tips on using FuGENE® HD Transfection Reagent to perform DNA transfection Mammalian cells - Primary cells Human pulmonary artery smooth muscle cells (HPASMC)

Products Promega FuGENE® HD Transfection Reagent

Get tips on using Lipofectamine® 2000 Transfection Reagent to perform DNA transfection Mammalian cells - Primary cells Human pulmonary artery smooth muscle cells (HPASMC)

Products Thermo Fisher Scientific Lipofectamine® 2000 Transfection Reagent

RNA RNA isolation / purification Tissue Human Colon

RNA RNA isolation / purification Tissue Human Saliva

DNA DNA isolation / purification Micorbiome Human skin

DNA DNA isolation / purification Micorbiome Human gut

Get tips on using TRIzol Reagent to perform RNA isolation / purification Cells - primary human pulmonary arterial smooth muscle cells

Products Thermo Fisher Scientific TRIzol Reagent

Get tips on using TRIzol Reagent to perform RNA isolation / purification Cells - primary human umbilical vein smooth muscle cells

Products Thermo Fisher Scientific TRIzol Reagent

Get tips on using TRIzol Reagent to perform RNA isolation / purification Cells - primary human umbilical artery smooth muscle cells

Products Thermo Fisher Scientific TRIzol Reagent

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms